(Q40657886)

22 September 2017

title

Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expression (English)

1 reference

22 September 2017

1 reference

Marc L Hyer

1

1 reference

22 September 2017

Sunil Sudarshan

2

1 reference

22 September 2017

David A Schwartz

3

1 reference

22 September 2017

Yusuf Hannun

4

1 reference

22 September 2017

Jian-yun Dong

5

1 reference

22 September 2017

James S Norris

6

1 reference

22 September 2017

publication date

1 April 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

10

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

330-339

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700576

22 September 2017

exact match

0 references

cites work

Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

Conditional gene targeting for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

Downregulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

Adenoviral vector which delivers FasL-GFP fusion protein regulated by the tet-inducible expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

Targeted gene delivery by tropism-modified adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

Apoptosis-inducing membrane vesicles. A novel agent with unique properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

Involvement of Fas (CD95/APO-1) and Fas ligand in apoptosis induced by ganciclovir treatment of tumor cells transduced with herpes simplex virus thymidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700576

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700576

1 reference

Dimensions Publication ID

22 September 2017

1028743843

0 references

1 reference